A novel method for bioinformatics analysis in gene expression profiling framework for personalized healthcare applications

In recent years, personalized health care has been propelled by patient-centric health plans enabled by customized medical technologies made possible by scientific and technological progress. Parkinson's disease treatment is being developed using genetic analysis of patients. In addition, the patients may have trouble moving around and communicating as the condition worsens. To make sense of biomedical data, the discipline of bioinformatics within nanotechnologies employs computational and mathematical techniques. Machine learning methods have recently advanced, making them much better at evaluating and predicting biological data if used appropriately. Hence, this article proposes a random forest-based algorithm on bioinformatics analysis in gene expression profiling (BA-GEP) framework for personalized healthcare for Parkinson's disease treatment. This research aims to examine gene sequences using machine learning techniques to discover groups with similar clinical characteristics of Parkinson's disease. First, indicated connectivity factor levels against every biomarker are used to determine differentially expressed areas based on the entire genome protein expression sequence information using the RF algorithm. Second, microarray technology helps convert genetic data from a biological source into a digital format. These findings provide light on the genetics and molecular basis of Parkinson's disease and may identify therapeutic options for the condition in the future. The outcome will aid in developing personalized medication recommendations by allowing the detection of variations that do not contribute to illness. The information may also be used to understand better genetic variation's role in determining how a person responds to a given treatment.